# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-104887
Filing Date
2024-04-22
Accepted
2024-04-22 16:18:58
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d830348dars.pdf | ARS | 788047
| Complete submission text file | 0001193125-24-104887.txt |  | 1086949

Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36332 | Film No.: 24861416
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)